Warner Chilcott and Paratek Pharmaceuticals have entered into an exclusive license agreement for the development and commercialization of novel, narrow-spectrum tetracyclines for the treatment of acne and rosacea.
From: www.pharmaceutical-business-review.com
Warner Chilcott, Paratek partner for acne and rosacea agents
Posted by Ruslan Abuzant at 9:02 PM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment